An Eight-week Study to Evaluate the Efficacy and Safety of 2 Doses of Saredutant in Patients With Generalized Anxiety Disorder

Clinical trial NCT00390533 · COMPLETED

Trial details

NCT number: NCT00390533
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Generalized Anxiety

Start date: 2006-09-01
Primary completion: 2008-02-01
Enrollment: 428

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.